Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study

被引:2
|
作者
Dassanayake, Tharaka L. [1 ,2 ]
Wijesundara, Devasmitha [1 ]
Kahathuduwa, Chanaka N. [3 ,4 ]
Weerasinghe, Vajira S. [1 ]
机构
[1] Univ Peradeniya, Fac Med, Dept Physiol, Peradeniya 20400, Sri Lanka
[2] Univ Newcastle, Sch Psychol Sci, Callaghan, NSW, Australia
[3] Texas Tech Univ, Sch Med, Dept Psychiat, Hlth Sci Ctr, Lubbock, TX USA
[4] Texas Tech Univ, Hlth Sci Ctr, Dept Lab Sci & Primary Care, Lubbock, TX 79430 USA
关键词
Theanine; attention; cognitive functions; reaction time; sustained attention; inhibitory control; stop-signal task; placebo-controlled trial; UNIQUE AMINO-ACID; STOP-SIGNAL; GREEN TEA; CAFFEINE; COMBINATION; COGNITION; CONSUMPTION; TASK;
D O I
10.1080/1028415X.2022.2136884
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: L-theanine is a non-protein-forming amino acid found in tea. Previous research shows high doses (100-400 mg) of L-theanine enhances attention, mainly by reducing mind wandering and distracter processing. We hypothesized that these indirect mechanisms could significantly improve the performance of low-level attentional tasks, whereas the relative contribution could be less in complex attentional tasks that require active, higher-order processing of target stimuli. Methods: To test this hypothesis, we conducted a double-blind, placebo-controlled, counterbalanced, four-way crossover study in 32 healthy young adults, where we compared the effects of three doses of L-theanine (100, 200 and 400 mg) with a placebo (distilled water), administered before and 50 min after dosing, on three attentional tasks from the Cambridge Neuropsychological Test Automated Battery [viz. Reaction Time (RTI)-visuomotor speed, Rapid Visual Information Processing (RVP)-sustained attention, and Stop Signal Task (SST)-inhibitory control]. Results were analyzed in dose x time repeated measures ANOVA models, with subsequent pairwise comparisons. Results: Active doses significantly improved reaction times in the RTI (100-200 mg) and RVP (200-400 mg) tasks from baseline (p < 0.05), but once controlled for the change-from-baseline caused by placebo, only the RTI simple reaction times showed significant improvements, following 100 mg (Delta = 16.3 ms, p = 0.009) and 200 mg (Delta = 16.9 ms, p = 0.009) of L-theanine. Conclusions: Consistent with our hypothesis, these findings suggest that L-theanine significantly improves attention in simple visuomotor tasks, but not in more complex sustained attention tasks, or executive control tasks that require top-down inhibition of pre-active responses.
引用
收藏
页码:1138 / 1146
页数:9
相关论文
共 50 条
  • [1] L-theanine improves neurophysiological measures of attention in a dose-dependent manner: a double-blind, placebo-controlled, crossover study
    Dassanayake, Tharaka L.
    Kahathuduwa, Chanaka N.
    Weerasinghe, Vajira S.
    NUTRITIONAL NEUROSCIENCE, 2022, 25 (04) : 698 - 708
  • [2] Effect of L-theanine on selective attention in a traffic-related reaction task in sleep-deprived young adults: a double-blind placebo-controlled, crossover study
    Karunaratne, Umangi W.
    Dassanayake, Tharaka L.
    NUTRITIONAL NEUROSCIENCE, 2024, : 471 - 480
  • [3] A Combination of Green Tea Extract and L-Theanine Improves Memory and Attention in Subjects with Mild Cognitive Impairment: A Double-Blind Placebo-Controlled Study
    Park, Sang-Ki
    Jung, In-Chul
    Lee, Won Kyung
    Lee, Young Sun
    Park, Hyoung Kook
    Go, Hyo Jin
    Kim, Kiseong
    Lim, Nam Kyoo
    Hong, Jin Tae
    Ly, Sun Yung
    Rho, Seok Seon
    JOURNAL OF MEDICINAL FOOD, 2011, 14 (04) : 334 - 343
  • [4] L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial
    Sarris, Jerome
    Byrne, Gerard J.
    Cribb, Lachlan
    Oliver, Georgina
    Murphy, Jenifer
    Macdonald, Patricia
    Nazareth, Sonia
    Karamacoska, Diana
    Galea, Samantha
    Short, Anika
    Ee, Carolyn
    Birling, Yoann
    Menon, Ranjit
    Ng, Chee H.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 110 : 31 - 37
  • [5] A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and mood
    Dodd, F. L.
    Kennedy, D. O.
    Riby, L. M.
    Haskell-Ramsay, C. F.
    PSYCHOPHARMACOLOGY, 2015, 232 (14) : 2563 - 2576
  • [6] Effect of single or combined caffeine and L-Theanine supplementation on shooting and cognitive performance in elite curling athletes: a double-blind, placebo-controlled study
    Yilmaz, Umut
    Buzdagli, Yusuf
    Polat, Muhammed Lutfu
    Bakir, Yusuf
    Ozhanci, Burak
    Alkazan, Sena
    Ucar, Halil
    JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2023, 20 (01)
  • [7] The Effects of L-Theanine (Suntheanine®) on Objective Sleep Quality in Boys with Attention Deficit Hyperactivity Disorder (ADHD): a Randomized, Double-blind, Placebo-controlled Clinical Trial
    Lyon, Michael R.
    Kapoor, Mahendra P.
    Juneja, Lekh R.
    ALTERNATIVE MEDICINE REVIEW, 2011, 16 (04) : 348 - 354
  • [8] A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and mood
    F. L. Dodd
    D. O. Kennedy
    L. M. Riby
    C. F. Haskell-Ramsay
    Psychopharmacology, 2015, 232 : 2563 - 2576
  • [9] L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial
    Ahmad Shamabadi
    Setareh Fattollahzadeh-Noor
    Bita Fallahpour
    Fatemeh A. Basti
    Mohammad-Reza Khodaei Ardakani
    Shahin Akhondzadeh
    Psychopharmacology, 2023, 240 : 2631 - 2640
  • [10] L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial
    Shamabadi, Ahmad
    Fattollahzadeh-Noor, Setareh
    Fallahpour, Bita
    A. Basti, Fatemeh
    Ardakani, Mohammad-Reza Khodaei
    Akhondzadeh, Shahin
    PSYCHOPHARMACOLOGY, 2023, 240 (12) : 2631 - 2640